Salih Ehsan/LinkedIn
Sep 15, 2026, 08:13
Salih Ehsan: Unraveling the Complex Phenotypes of TDT and NTDT
Salih Ehsan, Chief Executive Officer at Kulsoom Society of Hematology, shared a post on LinkedIn:
“TDTs and NTDTs phenotypes are complex entities, to understand them need a detective work about patient, parents and available close family members ( details history, examination, blood transfusion history of all family members, history of oral or iv iron trails failure, partial effect of oral folic acid or IM B12 , CBC with thalassemia signature, HPLC finding and then decision about molecular testing – a Gold standard) , I try my best to give the taste of both phenotypes.” 
Find more posts featuring Salih Ehsan on Hemostasis Today.
-
Nov 4, 2026, 03:51Riana Gjeta: Sharing Research on Blood Donor Safety in the Balkans
-
Nov 4, 2026, 03:48Umberto Pensato: World Stroke Congress – Science, Collaboration, and Recognition
-
Nov 4, 2026, 03:41Alejandro González Veliz: Understanding and Managing Stent Underexpansion
-
Nov 4, 2026, 03:26Violeta Jardin: The Evolution of Viscoelastic Testing
-
Nov 4, 2026, 03:12Daniele Sannipoli: Beyond Thrombosis Prevention in Polycythaemia Vera
-
Nov 4, 2026, 02:26Iris Paola Garcia Herrera: Antiphospholipid Antibodies in Children Beyond Thrombosis
-
Nov 4, 2026, 00:31Maria Cherska: Beyond LDL – Remnant Cholesterol and Stroke Prognosis
-
Nov 3, 2026, 22:00Ravi C Dara: What’s New in ASFA’s 10th Edition – Practical Updates for the Apheresis Clinician
-
Nov 3, 2026, 21:46Cedric Hermans: Treatment Differentiators for Shared Decision-Making in Haemophilia in 2026